Hester Biosciences Limited — Others, 12-11-2024: Appointment

Hester Biosciences has announced a board meeting on the appointment of Mr. Divyesh Maru as Chief Financial Officer, effective immediately. With over 15 years of experience in finance and management, Maru specializes in financial planning, audit, compliance, and ERP implementation, having held senior roles at notable firms including Baxter Pharmaceuticals and Deloitte. His appointment signals a strategic emphasis on strengthening the financial leadership, potentially enhancing operational efficiency and governance. This could contribute to a positive outlook among investors, as well-rounded leadership is crucial for navigating market challenges.